Hims & Hers Health Inc (NYSE:HIMS) shares have surged 32% to $50.48 since Tuesday's session open, following the company’s first-quarter earnings report released late Monday.
What To Know: The telehealth company posted first-quarter revenue of $586.01 million, exceeding analyst expectations of $538.2 million and marking a 111% year-over-year increase. Earnings per share came in at 20 cents, ahead of the 12 cents consensus.
Subscriber growth was a key driver, climbing 38% year-over-year to 2.4 million. Gross margin stood at 73%, with operating cash flow of $109.1 million and free cash flow of $50.1 million.
CEO Andrew Dudum highlighted strong momentum entering 2025, citing growing demand for accessible and personalized healthcare. The company reaffirmed full-year revenue guidance of $2.3 billion to $2.4 billion and projected at least $6.5 billion in annual revenue by 2030, alongside $1.3 billion in adjusted EBITDA.
Despite a slightly conservative second-quarter revenue outlook of $530–$550 million, compared to the expected $564.56 million estimates, investor enthusiasm remains high as the company shows progress scaling its platform.
Read Also: That Cake Is Already Baked,’ Says Bill Ackman, Warning U.S.-China Tariff War Is Driving Companies Out Of China For Good
How To Buy HIMS Stock
By now you're likely curious about how to participate in the market for Hims & Hers Health – be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of possible trading platforms here. Many will allow you to buy “fractional shares,” which allows you to own portions of stock without buying an entire share.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to “go short” a share of stock by lending you the shares to sell. The process of shorting a stock can be found at this resource. Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading – either way it allows you to profit off of the share price decline.
According to data from Benzinga Pro, HIMS has a 52-week high of $72.98 and a 52-week low of $11.64.
